Differential radiosensitisation by ZD1839 (Iressa), a highly selective epidermal growth factor receptor tyrosine kinase inhibitor in two related bladder cancer cell lines

The epidermal growth factor receptor (EGFR) is expressed in a wide variety of epithelial tumours including carcinoma of the bladder. Stimulation of the EGFR pathway is blocked by ZD1839 (Iressa), a highly selective EGFR tyrosine kinase inhibitor. Radical radiotherapy is an established organ sparing...

Descripción completa

Detalles Bibliográficos
Autores principales: Maddineni, S B, Sangar, V K, Hendry, J H, Margison, G P, Clarke, N W
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361738/
https://www.ncbi.nlm.nih.gov/pubmed/15611794
http://dx.doi.org/10.1038/sj.bjc.6602299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361738/
https://www.ncbi.nlm.nih.gov/pubmed/15611794
http://dx.doi.org/10.1038/sj.bjc.6602299

Ejemplares similares